Skip to main content
. 2002 Aug 12;87(4):385–392. doi: 10.1038/sj.bjc.6600486

Figure 1.

Figure 1

Comparative representation of the mean lymphocyte counts (per dl) and standard deviation in locally advanced non-small cell lung cancer patients treated in the present study (radiotherapy with Taxotere®/Caelyx® supported with amifostine) and in a previous phase II study of radiotherapy and Taxotere® (without amifostine).